Filter
284
Text search:
substandard
medicines
Featured
Recommendations
23
New Publications
100
Language
Document type
No document type
154
Studies & Reports
55
Guidelines
30
Strategic & Response Plan
18
Manuals
12
Fact sheets
5
Training Material
4
Situation Updates
4
Infographics
2
Countries / Regions
Kenya
13
Western and Central Europe
10
Uganda
9
Malawi
9
Ethiopia
8
India
8
Global
8
Nigeria
7
Sierra Leone
6
Tanzania
6
Rwanda
6
Liberia
5
Zambia
5
Myanmar / Burma
5
Ghana
4
Nepal
4
Syria
4
Cambodia
4
Bangladesh
4
Eswatini/ Swaziland
4
South–East Asia Region
4
Africa
4
Congo, Democratic Republic of
3
Zimbabwe
3
Namibia
3
Cameroon
2
Haiti
2
Philippines
2
Pakistan
2
Thailand
2
South Africa
2
Mozambique
2
Lesotho
2
Latin America and the Carribbean
2
Asia
2
Guinea
1
Jordan
1
Lebanon
1
Indonesia
1
Sudan
1
Central African Republic
1
North Macedonia
1
Ukraine
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Poland
1
Palestine
1
Laos
1
Canada
1
Vietnam
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
111
Public Health
18
Clinical Guidelines
18
Pharmacy & Technologies
10
Key Resources
5
Women & Child Health
3
Capacity Building
1
Annual Report MEDBOX
1
Toolboxes
AMR
51
Pharmacy
31
TB
26
HIV
12
COVID-19
10
Global Health Education
7
Conflict
6
Rapid Response
5
Planetary Health
5
Ebola
4
Refugee
4
Mental Health
4
Disability
2
Polio
2
NTDs
2
Specific Hazards
1
Caregiver
1
Health Financing Toolbox
1
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
2014-2020, Draft March 2014
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while f
...
PMPB/INS-GUIDE/02
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin
...
A survey of prevention, testing and treatment policies and practices
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was
...
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
PMPB/INS-GUIDE/04
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin
...